Naphthalenes
3-Bromo-2-naphthol 96.0+%, TCI America™
CAS: 30478-88-7 Molecular Formula: C10H7BrO Molecular Weight (g/mol): 223.07 MDL Number: MFCD10000951 InChI Key: PQVIOPAWVAOHOA-UHFFFAOYSA-N PubChem CID: 45943 IUPAC Name: 3-bromonaphthalen-2-ol SMILES: OC1=CC2=CC=CC=C2C=C1Br
Medchemexpress LLC Vardenafil hydrochloride trihydrate | 330808-88-3 | 100 MG
Vardenafil hydrochloride trihydrate is a selective and orally active inhibitor of phosphodiesterase-5 (PDE5), with an IC50 of 0.7 nM. It exhibits inhibitory activity against PDE1 (IC50 of 180 nM) and PDE6 (IC50 of 11 nM), while its IC50s are greater than 1000 nM for PDE3 and PDE4. This compound functions by competitively inhibiting cyclic guanosine monophosphate (cGMP) hydrolysis, thereby increasing cGMP levels. It is utilized in research for applications related to erectile dysfunction, hepatitis, and diabetes.
- Selective and orally active PDE5 inhibitor
- Competitively inhibits cGMP hydrolysis
- Increases cGMP levels
- Useful for research on erectile dysfunction, hepatitis, and diabetes
- IC50 for PDE5: 0.7 nM
- IC50 for PDE6: 11 nM
- IC50 for PDE1: 180 nM
- IC50 for PDE3: >1000 nM
- IC50 for PDE4: >1000 nM
Medchemexpress LLC Lurasidone hydrochloride | 367514-88-3 | 99.86% | C28H37ClN4O2S | 100 MG
Lurasidone hydrochloride is a chemical reagent from MedChemExpress that functions as an antagonist for both dopamine D2 and 5-HT7 receptors. It also acts as a partial agonist of the 5-HT1A receptor.
- Antagonist of dopamine D2 and 5-HT7 receptors
- Partial agonist of 5-HT1A receptor
- Suitable for neurological disease research
- Stable under recommended storage conditions
Medchemexpress LLC Vardenafil (hydrochloride trihydrate) | 330808-88-3 | 99.7% | 25 MG
Vardenafil hydrochloride trihydrate is a selective and orally active inhibitor of phosphodiesterase-5 (PDE5), with an IC50 of 0.7 nM. It competitively inhibits cyclic guanosine monophosphate (cGMP) hydrolysis, thereby increasing cGMP levels. This compound can be used for research related to erectile dysfunction, hepatitis, and diabetes.
- Selective and orally active inhibitor of phosphodiesterase-5 (PDE5).
- Inhibits PDE1 and PDE6 with IC50s of 180 nM and 11 nM.
- IC50s are >1000 nM for PDE3 and PDE4.
- Increases intracellular cGMP levels.
- Suitable for research of erectile dysfunction, hepatitis, and diabetes.
Medchemexpress LLC Lurasidone (Hydrochloride) | 367514-88-3 | 99.65% | 529.14 | 500 MG
Lurasidone (Hydrochloride) acts as an antagonist for dopamine D2 and 5-HT7 receptors, with IC50s of 1.68 nM and 0.495 nM, respectively. It also functions as a partial agonist for the 5-HT1A receptor, exhibiting an IC50 of 6.75 nM.
- Shows higher affinity for dopamine D2 and 5-HT2A receptors compared to other antipsychotics tested.
- Dose-dependently increases the DOPAC/dopamine ratio in both the frontal cortex and striatum, with a more pronounced effect on the frontal cortex at higher doses.
- Dose-dependently inhibits conditioned avoidance response (CAR) in rats.
- Dose-dependently inhibits TRY-induced forepaw clonic seizure and p-CAMP-induced hyperthermia.
Medchemexpress LLC Vardenafil hydrochloride trihydrate | 330808-88-3 | 99.7% | 1 ML
Vardenafil hydrochloride trihydrate is a selective and orally active inhibitor of phosphodiesterase-5 (PDE5), with an IC50 of 0.7 nM. It shows inhibitory effects towards PDE1 and PDE6 with IC50s of 180 nM and 11 nM, respectively, while its IC50s are >1000 nM for PDE3 and PDE4. This compound competitively inhibits cyclic guanosine monophosphate (cGMP) hydrolysis, thereby increasing cGMP levels.
- Selective and orally active inhibitor of phosphodiesterase-5 (PDE5).
- Competitively inhibits cyclic guanosine monophosphate (cGMP) hydrolysis.
- Increases cGMP levels.
- Can be used for research related to erectile dysfunction, hepatitis, and diabetes.
Sigma Aldrich Fine Chemicals Biosciences 3-Bromo-2-naphthol 99% | 30478-88-7 | MFCD10000951 | 1G
3-Bromo-2-naphthol 99% | Purity: >=98.5% (HPLC); 99% | Mol Wt: 223.07 | 30478-88-7 | MFCD10000951 | 1G
eMolecules Synthonix - Stock / 3-Fluoro-4-(tributylstannyl)-pyridine / 1g / 525917760 / F6856 / / 259807-88-0 / MFCD11044865 / 386.142 / C17H30FNSn
Synthonix - Stock / 3-Fluoro-4-(tributylstannyl)-pyridine / 1g / 525917760 / F6856 / / 259807-88-0 / MFCD11044865 / 386.142 / C17H30FNSn
![eMolecules Combi-Blocks Inc. Benzyl 2-oxa-3-azabicyclo[2.2.1]hept-5-ene-3-carboxylate 5g 794200123 JP-6744 95.000 99027-88-0 MFCD22683220 231.251 C13H13NO3](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502694639.jpg-250.jpg)
eMolecules Combi-Blocks Inc. Benzyl 2-oxa-3-azabicyclo[2.2.1]hept-5-ene-3-carboxylate 5g 794200123 JP-6744 95.000 99027-88-0 MFCD22683220 231.251 C13H13NO3
Combi-Blocks Inc. Benzyl 2-oxa-3-azabicyclo[2.2.1]hept-5-ene-3-carboxylate 5g 794200123 JP-6744 95.000 99027-88-0 MFCD22683220 231.251 C13H13NO3
![eMolecules Combi-Blocks Inc. L-Valine n-[(11-dimethylethoxy)carbonyl]-3-methyl- methyl ester 25g 784501367 YC-1475 95.000 176504-88-4 MFCD11113188 245.319 C12H23NO4](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502694671.jpg-250.jpg)
eMolecules Combi-Blocks Inc. L-Valine n-[(11-dimethylethoxy)carbonyl]-3-methyl- methyl ester 25g 784501367 YC-1475 95.000 176504-88-4 MFCD11113188 245.319 C12H23NO4
Combi-Blocks Inc. L-Valine n-[(11-dimethylethoxy)carbonyl]-3-methyl- methyl ester 25g 784501367 YC-1475 95.000 176504-88-4 MFCD11113188 245.319 C12H23NO4
Sigma Aldrich 3-Bromo-2-naphthol
MilliporeSigma Sigma Organics products encompass a wide range of quality reagents, solvents, catalysts, and building blocks for organic synthesis. From benchtop discovery to process development and scale-up, Sigma Organics solutions are built to meet the needs of synthetic chemists.